Skip to main content
OpenTrials
Completed

NCT Number: NCT01113138

Study of the Metabolism of Two Magnesium Supplements in Healthy Volunteers

The present study is part of a project titled 'Magnesium in asthma and chronic obstructive pulmonary disease'. The hypothesis of the main project is that daily magnesium supplement will benefit patients with asthma and chronic obstructive pulmonary disease.

The aim of this part of the project is to study the pharmacokinetics of the following two magnesium supplements:

* Mablet (dietary supplement) * Magnesium Sulfate (solution for infusion)

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Asthma Bronchial Diseases Chronic Disease Chronic Obstructive Pulmonary Disease Disease Attributes Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Respiratory Hypersensitivity Respiratory Tract Diseases

Age range

18 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Research Dept. of Respiratory Medicine, Aarhus University Hospital

Aarhus C, 8000, Denmark

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy volunteers.

Exclusion criteria

  • Smokers,
  • Using pharmaceuticals/supplements,
  • Vegans/vegetarians,
  • Major changes in eating habits within one week prior to study start.

Treatment and study plan

Mablet (Magnesium-supplement)

Dietary Supplement

Mablet: Magnesium hydroxide/ -oxide (360 mg/tablet) 3 tablets as a single dose Produced by: Gunnar Kjems APS

Other names: Mablet

Magnesium sulfate

Drug

Solution for a single bolus-infusion, containing 2 grams of magnesium sulfate.

Other names: Magnesiumsulfat 'SAD'

Primary outcomes

  1. Pharmacokinetic parameters

    Time frame: Two years

    Clearance, half-life & absorption fraction

Sponsors and collaborators

Lead sponsor

University of Aarhus

Other

Collaborators

  • Aarhus University Hospital
  • GCP-unit at Aarhus University Hospital, Aarhus, Denmark
  • Gunnar Kjems APS

Registry information

Official study title

Pharmacokinetic Study of Mablet as Oral Supplement and Magnesium Sulfate as Infusion

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
Apr 29, 2010
Registry last updated
Jan 13, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.